THIS IS AN ADVERTISEMENT AND NOT AN OFFER OF SHARES. IT IS DIRECTED ONLY AT PERSONS TAX RESIDENT AND LOCATED IN THE UK AND IS NOT FOR DISTRIBUTION IN THE US. Share prices may go down, you may get back less than you put in.
Read the U.S. prospectus (the U.S. Prospectus) and the disclosure summary (the Disclosure Summary) before investing. These are available at www.freetrade.io/ipo/spacex. The offer of shares is made through Marex Financial's public offer platform.
A registration statement on Form S-1 relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. Copies of the U.S. Prospectus, when available, may be obtained for free by visiting EDGAR on the SEC's website at www.sec.gov. No offer to buy the securities can be accepted and no part of the purchase price can be received until the registration statement has become effective, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to notice of its acceptance given after the effective date.
Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed on the adequacy or accuracy of the U.S. Prospectus. Any representation to the contrary is a criminal offense.
Whilst the U.S. Prospectus is referred to as a 'prospectus', neither the U.S. Prospectus nor the Disclosure Summary is a prospectus for the purposes of The Public Offers and Admissions to Trading Regulations 2024 (the POATRs) or the UK Financial Conduct Authority (FCA) Handbook Admission to Trading on a Regulated Market Sourcebook (the PRM Sourcebook). Neither the U.S. Prospectus nor the Disclosure Summary has been approved by the FCA and the U.S. Prospectus and the Disclosure Summary may not contain the same information as would be included in a prospectus for the purposes of the POATRs or the PRM Sourcebook.
The securities of the Company will not be admitted to listing to the Official List of the FCA or admitted to trading on a regulated market or primary MTF (as such terms are defined in the POATRs) in the United Kingdom.
You should read the U.S. Prospectus and the Disclosure Summary before deciding to participate in the offer in order to fully understand the potential risks and rewards before investing. If you are in any doubt about investing, contact an independent financial adviser.
This advertisement is prepared by and is the sole responsibility of Freetrade Limited, a firm authorised and regulated by the Financial Conduct Authority.
No offer or invitation to purchase securities in any jurisdiction is being made by the Company and, to the fullest extent permitted by law, each of the Company and its directors, employees, agents and affiliates disclaim any liability or responsibility to actual or potential investors who invest in securities of the Company pursuant to the offer by Marex Financial made through its public offer platform.
By accessing this website, you warrant that you are tax resident and located in the United Kingdom and you are not physically present in the United States or any other jurisdiction outside of the United Kingdom, and you agree that you will not transmit or otherwise send any of the information to persons outside the United Kingdom.
Freetrade will receive a commission from Marex Financial of 0.2% of the value of the shares allocated for participating in this offer. Freetrade does not provide investment advice or recommend that you apply. You should make your own decision using the offer documents and considering your own circumstances.
